Current Report Filing (8-k)
September 20 2022 - 03:21PM
Edgar (US Regulatory)
0001419051
false
0001419051
2022-09-19
2022-09-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): September
19, 2022
THERAPEUTIC
SOLUTIONS INTERNATIONAL, INC.
(Exact
Name of Registrant as Specified in its Charter)
Nevada |
|
000-54554 |
|
45-1226465 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
Number) |
701
Wild Rose Lane
Elk
City, Idaho
83525
(Address
of Principal Executive Offices and Zip Code)
(760)
295-7208
(Issuer’s
telephone number)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock |
|
TSOI |
|
OTC
Markets |
Item
1.01 Entry into a Material Definitive Agreement.
On
September 19, 2022, Therapeutic Solutions International, Inc., entered into an agreement with GHS Investments, LLC (“GHS”)
to purchase up to $10,000,000 of Registered Common Stock.
Item
9.01 Financial Statements and Exhibits.
Exhibit
Index
(99.1)
TSOI Securities Purchase Agreement
(99.2)
Press release dated September 20, 2022, issued by Therapeutic Solutions International, Inc.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
September 20, 2022
THERAPEUTIC
SOLUTIONS INTERNATIONAL, INC. |
|
|
|
By:
|
/s/
Timothy Dixon |
|
|
Timothy
Dixon |
|
|
Chief
Executive Officer |
|
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Mar 2023 to Mar 2024